EB-2 (NIW) Visa Cases: syria

USCIS I-140 petition data for syria nationals (FY2025 Q4 (Jul-Sep 2025)).

16 I-140 petitions · 5 approved · #73 by volume

View Dashboard Search Endeavours

Subcategory:

USCIS I-140 Data

syria I-140 Petition Statistics

USCIS EB-2 (NIW) petition data for syria nationals. FY2025 Q4 (Jul-Sep 2025).

I-140 Receipts

0.1% of all

I-140 Approvals

of 5,929 total

Volume Rank

#73

by I-140 receipts

Source: USCIS I-140 Performance Data, FY2025 Q4 (Jul-Sep 2025). Receipts and approvals for the reporting quarter.

Priority Date Tracker

Final Action Date

Oct 2024

ROW Final Action

Oct 2024

Source: DOS Visa Bulletin (2026-03)

Wait Time Estimator

Estimate Your Green Card Timeline

Enter your priority date and country to get a personalized estimate based on average DOS Final Action Date advancement over the last 12 months.

Your Priority Date

Chargeability Country

Visa Category

EB-2 (incl. NIW)

Sources: I-140/I-485 ranges from USCIS Processing Times, backlog advancement averaged over last 12 DOS Visa Bulletins. Estimates only.

Find syria EB-2 (NIW) Cases

Browse real petition decisions and case studies from syria, or join the waitlist to get notified when personalized case matching launches.

Browse Cases Search Endeavours

Join the waitlist for case matching.

Country Comparison

USCIS I-140 data, FY2025 Q4 (Jul-Sep 2025)

Country	Receipts	Approvals
Grand Total	13,983	2,968
China	2,330	715
India	1,685	426
Syria (current)	16	5

Case Data Insights

We analyzed 6 publicly available EB-2 (NIW) petition decisions involving syria nationals. Of these, 100% were approved or sustained. These cases span 3 industries and 5 job titles. Explore the charts below to see how decision outcomes have trended over time and which industries and roles have the highest success rates.

Decision Trends

Approved

Remanded

Denied

Top Industries

Pharmaceuticals 3

Healthcare 2

Artificial Intelligence 1

Top Job Titles

Assistant Professor 1

Chief Executive Officer (CEO) 1

Doctor 1

Lecturer 1

Medical Laboratory Technician 1

Policy Updates

General View all

Mar 2026 info Visa Bulletin

Visa Bulletin Update: EB-2 (2026-03)

The Department of State updated EB-2 Final Action Dates in the 2026-03 Visa Bulletin: - India: moved from 2013-07-15 to 2013-09-15 - Philippines: moved from 2024-04-01 to 2024-10-15 - Mexico: moved from 2024-04-01 to 2024-10-15 - Rest of World: moved from 2024-04-01 to 2024-10-15 This may allow additional applicants to proceed with their petitions.

advancementeb-2final-action-datepriority-date

Feb 2026 info Executive Order

Protecting the National Security and Welfare of the United States and its Citizens from Criminal Actors and Other Public Safety Threats

The policy directs DHS to maximize its use of criminal history record information (CHRI) for screening and vetting missions. This includes reciprocal data sharing with foreign governments, which will likely be utilized during the adjudication of EB-2 visas and National Interest Waivers.

vettingbackground checkssecurity screeningNIW

Jan 2026 warning USCIS Alert

USCIS to Increase Premium Processing Fees

The fee for Form I-907 is being adjusted upwards, impacting EB-2 petitioners who utilize expedited processing. This change is part of a broader USCIS effort to adjust fees for inflation and maintain service levels.

premium processinguscis feesNIWform i-907

Jan 2026 warning USCIS Memo

DHS Launches Landmark USCIS Fraud Investigation in Minnesota

The investigation focuses on identifying fraudulent activities within USCIS filings in the Minnesota region. EB-2 applicants may experience heightened vetting procedures, including more frequent Requests for Evidence (RFEs) and audits of employer credentials. This initiative is part of a broader DHS effort to ensure the integrity of employment-based immigration programs.

fraud investigationcomplianceUSCISDHS

Jan 2026 info Visa Bulletin

Visa Bulletin Update: EB-2 (2026-01)

The Department of State updated EB-2 Final Action Dates in the 2026-01 Visa Bulletin: - India: moved from 2013-05-15 to 2013-07-15 - China: moved from 2021-06-01 to 2021-09-01 - Philippines: moved from 2024-02-01 to 2024-04-01 - Mexico: moved from 2024-02-01 to 2024-04-01 - Rest of World: moved from 2024-02-01 to 2024-04-01 This may allow additional applicants to proceed with their petitions.

advancementeb-2final-action-datepriority-date

Frequently Asked Questions

At a Glance

USCIS Official Data

I-140 Receipts 16

I-140 Rank #73 of 191

Scraped Case Data

Decisions 6

Success Rate 100%

Country Share 0.2%

Approved / Sustained 6

Denied / Dismissed 0

Top Industry Pharmaceuticals

Top Job Title Assistant Professor

Recent Decisions

View all

Doctor

Healthcare · Syria

WeGreened approved

Ohio 603 days 2025-10-11

The petitioner proposes to continue advancing patient-centric healthcare and medical research in the United States. Their work focuses on clinical practices and public health strategies, specifically addressing COVID-19 vaccination awareness, artificial intelligence in clinical settings, cardiac electrophysiology, and therapeutic optimization for cancer treatments. The endeavor aims to improve patient outcomes and strengthen U.S. public health systems through evidence-based care.

View Case

Medical Laboratory Technician

Healthcare · Syria

WeGreened rfe approved

608 days 2025-08-06

The petitioner proposes to continue research in laboratory medicine focusing on the mechanisms of complex medical conditions, including autoimmune and vascular disorders. The work involves investigating specific antibodies and proteins to improve diagnostic accuracy and identify new therapeutic targets. This endeavor aims to reduce misdiagnoses and enable more effective clinical treatments for chronic and rare diseases.

View Case

Chief Executive Officer (CEO)

Artificial Intelligence · Syria

WeGreened approved

200 days 2025-06-25

The petitioner proposes to lead scientific initiatives building machine learning models that accelerate the drug discovery process, specifically focusing on simulating molecular interactions to design personalized cancer treatments. Her work aims to address bottlenecks in drug development by blending multi-omics data with predictive AI systems to reduce costs and increase precision.

View Case

Others

Pharmaceuticals · Syria

WeGreened approved

343 days 2025-05-13

The petitioner proposes to develop next-generation controlled-release drug delivery systems (CRDDSs) that release medications at controlled rates to improve efficacy and patient compliance for chronic diseases like diabetes and hypertension. His work involves integrating botanical materials into drug matrices to create low-cost, biocompatible alternatives to synthetic excipients. He plans to collaborate with U.S. pharmaceutical institutions to explore liposomal systems and stimuli-responsive materials for enhanced drug release.

View Case

Lecturer

Pharmaceuticals · Syria

WeGreened approved

Malaysia 173 days 2023-02-01

The petitioner proposes to develop new oral insulin delivery materials and drug delivery carriers using a one-step reproducible process. This work aims to develop DNA and RNA vaccines to treat cancer and other diseases, specifically focusing on nanoparticle-based systems that preserve insulin through stomach acid.

View Case